The usual dosage for adult and children with body weight of ≥ 20 kg for oral use is 250 mg (potency) of Cefalexin every 6 hours.
The dosage for severe cases and cases whose isolated microorganisms show relatively low susceptibility for oral use is 500 mg (potency) of Cefalexin every 6 hours.
The dosage may be adjusted according to the patient’s age, body weight and symptoms.
Cefalexin-susceptible strains of Staphylococcus sp., Streptococcus sp., Pneumococcus, Enterococcus sp., Gonococcus, Escherichia coli, Klebsiella sp., Enterobacter sp., Proteus sp., Morganella morganii, Providencia sp., Haemophilus influenzae
Superficial skin infection, deep skin infection, lymphangitis or lymphadenitis, chronic pyoderma, secondary infection in trauma, burn or surgical wound, etc., mastitis, osteomyelitis, myositis, pharyngitis or laryngitis, tonsillitis, acute bronchitis, pneumonia, secondary infection in chronic respiratory disease, cystitis, pyelonephritis, prostatitis (acute, chronic), epididymitis, gonococcal infection, cervicitis, bartholinitis, intrauterine infection, dacryocystitis, hordeolum, keratitis (including corneal ulcer), otitis externa, otitis media, sinusitis, purulent sialoadenitis, periodontal tissue inflammation, pericoronitis, maxillary sinusitis, jaw inflammation, secondary infection in tooth extraction or oral surgery wound
Cefalexin - 250 mg (Potency)